Follow-up Infarct Volume As a Mediator of Endovascular Treatment Effect on Functional Outcome in Ischaemic Stroke

Overview

Journal Eur Radiol

Specialty Radiology

Date 2018 Jul 11

PMID 29987421

Citations 12

Authors

K C J Compagne

A M M Boers

H A Marquering

O A Berkhemer

A J Yoo

L F M Beenen

R J van Oostenbrugge

W H van Zwam

Y B W E M Roos

C B Majoie

A C G M van Es

A van der Lugt

D W J Dippel

H Lingsma

Affiliations

Soon will be listed here.

Abstract

Objective: The putative mechanism for the favourable effect of endovascular treatment (EVT) on functional outcome after acute ischaemic stroke is preventing follow-up infarct volume (FIV) progression. We aimed to assess to what extent difference in FIV explains the effect of EVT on functional outcome in a randomised trial of EVT versus no EVT (MR CLEAN).

Methods: FIV was assessed on non-contrast CT scan 5-7 days after stroke. Functional outcome was the score on the modified Rankin Scale at 3 months. We tested the causal pathway from intervention, via FIV to functional outcome with a mediation model, using linear and ordinal regression, adjusted for relevant baseline covariates, including stroke severity. Explained effect was assessed by taking the ratio of the log odds ratios of treatment with and without adjustment for FIV.

Results: Of the 500 patients included in MR CLEAN, 60 died and four patients underwent hemicraniectomy before FIV was assessed, leaving 436 patients for analysis. Patients in the intervention group had better functional outcomes (adjusted common odds ratio (acOR) 2.30 (95% CI 1.62-3.26) than controls and smaller FIV (median 53 vs. 81 ml) (difference 28 ml; 95% CI 13-41). Smaller FIV was associated with better outcome (acOR per 10 ml 0.60, 95% CI 0.52-0.68). After adjustment for FIV the effect of intervention on functional outcome decreased but remained substantial (acOR 2.05, 95% CI 1.44-2.91). This implies that preventing FIV progression explains 14% (95% CI 0-34) of the beneficial effect of EVT on outcome.

Conclusion: The effect of EVT on FIV explains only part of the treatment effect on functional outcome.

Key Points: • Endovascular treatment in acute ischaemic stroke patients prevents progression of follow-up infarct volume on non-contrast CT at 5-7 days. • Follow-up infarct volume was related to functional outcome, but only explained a modest part of the effect of intervention on functional outcome. • A large proportion of treatment effect on functional outcome remains unexplained, suggesting FIV alone cannot be used as an early surrogate imaging marker of functional outcome.

Citing Articles

Infarct density defined by ADC threshold is associated with long-term functional outcome after endovascular thrombectomy.

Favilla C, Patel H, Abassi M, Thon J, Mullen M, Kasner S J Stroke Cerebrovasc Dis. 2024; 33(10):107857.

PMID: 38997048 PMC: 11380574. DOI: 10.1016/j.jstrokecerebrovasdis.2024.107857.

Introducing the Futile Recanalization Prediction Score (FRPS): A Novel Approach to Predict and Mitigate Ineffective Recanalization after Endovascular Treatment of Acute Ischemic Stroke.

Shen H, Huasen B, Killingsworth M, Bhaskar S Neurol Int. 2024; 16(3):605-619.

PMID: 38921949 PMC: 11206671. DOI: 10.3390/neurolint16030045.

Effect of Endovascular Thrombectomy for Acute Ischemic Stroke on Cognitive Outcomes: A Secondary Analysis of the ESCAPE Trial.

Joundi R, Smith E, Mandzia J, Ganesh A, Menon B, Rempel J Neurology. 2024; 102(10):e209270.

PMID: 38739880 PMC: 11177593. DOI: 10.1212/WNL.0000000000209270.

Priorities for Advancements in Neuroimaging in the Diagnostic Workup of Acute Stroke.

Samaniego E, Boltze J, Lyden P, Hill M, Campbell B, Silva G Stroke. 2023; 54(12):3190-3201.

PMID: 37942645 PMC: 10841844. DOI: 10.1161/STROKEAHA.123.044985.

Duration of Ischemia Affects Outcomes Independent of Infarct Size in Stroke.

Kim Y, Khose S, Zaidat O, Hassan A, Fifi J, Nanda A Stroke Vasc Interv Neurol. 2023; 2(5).

PMID: 37377482 PMC: 10296784. DOI: 10.1161/svin.121.000163.

References

Al-Ajlan F, Al Sultan A, Minhas P, Assis Z, De Miquel M, Millan M . Posttreatment Infarct Volumes when Compared with 24-Hour and 90-Day Clinical Outcomes: Insights from the REVASCAT Randomized Controlled Trial. AJNR Am J Neuroradiol. 2017; 39(1):107-110. PMC: 7410691. DOI: 10.3174/ajnr.A5463. View

Marcoux F, Morawetz R, CROWELL R, DeGirolami U, Halsey Jr J . Differential regional vulnerability in transient focal cerebral ischemia. Stroke. 1982; 13(3):339-46. DOI: 10.1161/01.str.13.3.339. View

Saver J, JOHNSTON K, Homer D, Wityk R, Koroshetz W, Truskowski L . Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials. The RANTTAS Investigators. Stroke. 1999; 30(2):293-8. DOI: 10.1161/01.str.30.2.293. View

Freedman L, Graubard B, Schatzkin A . Statistical validation of intermediate endpoints for chronic diseases. Stat Med. 1992; 11(2):167-78. DOI: 10.1002/sim.4780110204. View

Lansberg M, OBrien M, Tong D, Moseley M, Albers G . Evolution of cerebral infarct volume assessed by diffusion-weighted magnetic resonance imaging. Arch Neurol. 2001; 58(4):613-7. DOI: 10.1001/archneur.58.4.613. View

Al-Ajlan F, Goyal M, Demchuk A, Minhas P, Sabiq F, Assis Z . Intra-Arterial Therapy and Post-Treatment Infarct Volumes: Insights From the ESCAPE Randomized Controlled Trial. Stroke. 2016; 47(3):777-81. DOI: 10.1161/STROKEAHA.115.012424. View

Moons K, Donders R, Stijnen T, Harrell Jr F . Using the outcome for imputation of missing predictor values was preferred. J Clin Epidemiol. 2006; 59(10):1092-101. DOI: 10.1016/j.jclinepi.2006.01.009. View

Ebinger M, Christensen S, De Silva D, Parsons M, Levi C, Butcher K . Expediting MRI-based proof-of-concept stroke trials using an earlier imaging end point. Stroke. 2009; 40(4):1353-8. DOI: 10.1161/STROKEAHA.108.532622. View

Barrett K, Ding Y, Wagner D, Kallmes D, Johnston K . Change in diffusion-weighted imaging infarct volume predicts neurologic outcome at 90 days: results of the Acute Stroke Accurate Prediction (ASAP) trial serial imaging substudy. Stroke. 2009; 40(7):2422-7. PMC: 2772139. DOI: 10.1161/STROKEAHA.109.548933. View

10.

Lansberg M, Lee J, Christensen S, Straka M, De Silva D, Mlynash M . RAPID automated patient selection for reperfusion therapy: a pooled analysis of the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) and the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) Study. Stroke. 2011; 42(6):1608-14. PMC: 3104106. DOI: 10.1161/STROKEAHA.110.609008. View

11.

Payabvash S, Souza L, Wang Y, Schaefer P, Furie K, Halpern E . Regional ischemic vulnerability of the brain to hypoperfusion: the need for location specific computed tomography perfusion thresholds in acute stroke patients. Stroke. 2011; 42(5):1255-60. PMC: 3090217. DOI: 10.1161/STROKEAHA.110.600940. View

12.

Ernst M, Boers A, Aigner A, Berkhemer O, Yoo A, Roos Y . Association of Computed Tomography Ischemic Lesion Location With Functional Outcome in Acute Large Vessel Occlusion Ischemic Stroke. Stroke. 2017; 48(9):2426-2433. DOI: 10.1161/STROKEAHA.117.017513. View

13.

Boers A, Marquering H, Jochem J, Besselink N, Berkhemer O, van der Lugt A . Automated cerebral infarct volume measurement in follow-up noncontrast CT scans of patients with acute ischemic stroke. AJNR Am J Neuroradiol. 2013; 34(8):1522-7. PMC: 8051473. DOI: 10.3174/ajnr.A3463. View

14.

Simonsen C, Yoo A, Sorensen L, Juul N, Johnsen S, Andersen G . Effect of General Anesthesia and Conscious Sedation During Endovascular Therapy on Infarct Growth and Clinical Outcomes in Acute Ischemic Stroke: A Randomized Clinical Trial. JAMA Neurol. 2018; 75(4):470-477. PMC: 5885172. DOI: 10.1001/jamaneurol.2017.4474. View

15.

Valeri L, VanderWeele T . Mediation analysis allowing for exposure-mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macros. Psychol Methods. 2013; 18(2):137-50. PMC: 3659198. DOI: 10.1037/a0031034. View

16.

Prentice R . Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med. 1989; 8(4):431-40. DOI: 10.1002/sim.4780080407. View

17.

VanderWeele T, Vansteelandt S . Odds ratios for mediation analysis for a dichotomous outcome. Am J Epidemiol. 2010; 172(12):1339-48. PMC: 2998205. DOI: 10.1093/aje/kwq332. View

18.

Berkhemer O, Fransen P, Beumer D, van den Berg L, Lingsma H, Yoo A . A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2014; 372(1):11-20. DOI: 10.1056/NEJMoa1411587. View

19.

van der Heijden G, Donders A, Stijnen T, Moons K . Imputation of missing values is superior to complete case analysis and the missing-indicator method in multivariable diagnostic research: a clinical example. J Clin Epidemiol. 2006; 59(10):1102-9. DOI: 10.1016/j.jclinepi.2006.01.015. View

20.

Adams Jr H, Davis P, Leira E, Chang K, Bendixen B, Clarke W . Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology. 1999; 53(1):126-31. DOI: 10.1212/wnl.53.1.126. View